PCV7 a Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients With Non-Valvular Atrial Fibrillation (NVAF)

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.950
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation

Heart and Vessels
Cardiovascular MedicineCardiology
2018English

Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Left Atrial Strain Predicts Pro-Thrombotic State in Patients With Non-Valvular Atrial Fibrillation

Journal of Atrial Fibrillation
Cardiovascular MedicineCardiology
2017English

Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Economic Impact Associated With Cerebrovascular Events Related to Non-Valvular Atrial Fibrillation (NVAF) in Italy: The Role of Apixaban

Farmeconomia. Health economics and therapeutic pathways
2014English

Clinical Analysis of Antithrombotic Treatment and Occurrence of Stroke in Elderly Patients With Non-Valvular Persistent Atrial Fibrillation

Clinical Cardiology
MedicineCardiovascular MedicineCardiology
2018English

Cost-Effectiveness of Apixaban for Stroke Prevention in Non-Valvular Atrial Fibrillation in Saudi Arabia

Annals of Saudi Medicine
Medicine
2019English

Reducing the Risk of Stroke in Elderly Patients With Non-Valvular Atrial Fibrillation: A Practical Guide for Clinicians

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2017English

Secondary Prevention in Patients With Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?

European Cardiology Review
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy